(NASDAQ: AFIB) Acutus Medical's forecast annual revenue growth rate of 24.56% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 72.18%.
Acutus Medical's revenue in 2023 is $15,763,000.On average, 2 Wall Street analysts forecast AFIB's revenue for 2023 to be $558,659,870, with the lowest AFIB revenue forecast at $554,818,817, and the highest AFIB revenue forecast at $562,500,923.
In 2024, AFIB is forecast to generate $877,751,820 in revenue, with the lowest revenue forecast at $877,751,820 and the highest revenue forecast at $877,751,820.